Screening test to find early prostate cancer sooner
Part of Cancer, Kidney & urinary clinical trials.
This trial checks whether an early prostate cancer screening approach can detect clinically significant prostate cancer sooner. It may help participants catch the disease at an earlier stage when treatment can be more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a man who is 50 to 63 years old (based on your age in 2018)
- Live in Tampere or Helsinki
- Have not been diagnosed with prostate cancer before (no known/prevalent prostate cancer)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial aims to raise awareness and screen for prostate cancer in men aged 50 to 69 across the European Union. You may be able to join if you have never been diagnosed with prostate cancer and haven't had a prostate biopsy or MRI in the last six months.
This trial is testing a simple finger-prick blood test to measure prostate-specific antigen (PSA) for prostate cancer screening. It aims to make screening easier and more accessible.
This study is testing an approach to find prostate cancer earlier in men who may be at higher risk. If you fit the criteria, you may get an mpMRI scan before undergoing a prostate biopsy to check for cancer.
This study looks at how genetic risk and regular screening can help find prostate cancer earlier. It may help you and other Veterans understand what screening is best for different risk levels and access needs.
This study tests a new way to screen for prostate cancer in men aged 55 to 65 who live in a specific area of Italy. It aims to find cancer early when it's easier to treat.
This study enrolls men who may have prostate cancer but do not yet have a diagnosis. It uses prostate MRI along with blood and urine tests to see if specific signals can help identify prostate cancer sooner.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.